Nature // Petrie-Flom Center
Following the US drug agency’s decision, Nature examines the outlook for other hallucinogens that are in clinical trials as psychiatric treatments. By Sara Reardon, featuring I. Glenn Cohen and Mason Marks.
FDA rejects ecstasy as a therapy: what’s next for psychedelics?